HRP20200155T1 - Farmaceutski pripravak koji obuhvaća drospirenon i kontracepcijski komplet - Google Patents
Farmaceutski pripravak koji obuhvaća drospirenon i kontracepcijski komplet Download PDFInfo
- Publication number
- HRP20200155T1 HRP20200155T1 HRP20200155TT HRP20200155T HRP20200155T1 HR P20200155 T1 HRP20200155 T1 HR P20200155T1 HR P20200155T T HRP20200155T T HR P20200155TT HR P20200155 T HRP20200155 T HR P20200155T HR P20200155 T1 HRP20200155 T1 HR P20200155T1
- Authority
- HR
- Croatia
- Prior art keywords
- drospirenone
- daily
- contraceptive
- units
- preparation
- Prior art date
Links
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title claims 21
- 229960004845 drospirenone Drugs 0.000 title claims 21
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title claims 20
- 239000003433 contraceptive agent Substances 0.000 title claims 17
- 230000002254 contraceptive effect Effects 0.000 title claims 17
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims 7
- 239000002245 particle Substances 0.000 claims 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims 6
- 239000000314 lubricant Substances 0.000 claims 4
- 238000004806 packaging method and process Methods 0.000 claims 4
- 239000011230 binding agent Substances 0.000 claims 3
- 239000000945 filler Substances 0.000 claims 3
- 239000000902 placebo Substances 0.000 claims 3
- 229940068196 placebo Drugs 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 238000007922 dissolution test Methods 0.000 claims 2
- 229940011871 estrogen Drugs 0.000 claims 2
- 239000000262 estrogen Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical group O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 229960004977 anhydrous lactose Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 235000012239 silicon dioxide Nutrition 0.000 claims 1
- 239000012748 slip agent Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305708 | 2010-06-29 | ||
| US36839610P | 2010-07-28 | 2010-07-28 | |
| EP11727985.1A EP2588114B1 (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit |
| PCT/EP2011/060795 WO2012000981A1 (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20200155T1 true HRP20200155T1 (hr) | 2020-05-01 |
Family
ID=48802149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20200155TT HRP20200155T1 (hr) | 2010-06-29 | 2020-01-30 | Farmaceutski pripravak koji obuhvaća drospirenon i kontracepcijski komplet |
Country Status (14)
| Country | Link |
|---|---|
| KR (1) | KR102210982B1 (lt) |
| BR (1) | BR122019008317A2 (lt) |
| CL (1) | CL2012003685A1 (lt) |
| CO (1) | CO6640328A2 (lt) |
| DK (1) | DK2588114T3 (lt) |
| EC (3) | ECSP12012359A (lt) |
| ES (1) | ES2777886T3 (lt) |
| GT (3) | GT201200336A (lt) |
| HR (1) | HRP20200155T1 (lt) |
| HU (1) | HUE047689T2 (lt) |
| LT (2) | LT2588114T (lt) |
| MX (3) | MX364971B (lt) |
| PT (1) | PT2588114T (lt) |
| ZA (1) | ZA201209743B (lt) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009138224A1 (en) * | 2008-05-14 | 2009-11-19 | Helm Ag | Pharmaceutical composition comprising drospirenone |
-
2011
- 2011-06-28 MX MX2015008884A patent/MX364971B/es unknown
- 2011-06-28 BR BR122019008317-7A patent/BR122019008317A2/pt not_active Application Discontinuation
- 2011-06-28 DK DK11727985.1T patent/DK2588114T3/da active
- 2011-06-28 LT LTEP11727985.1T patent/LT2588114T/lt unknown
- 2011-06-28 HU HUE11727985A patent/HUE047689T2/hu unknown
- 2011-06-28 MX MX2012014629A patent/MX339952B/es active IP Right Grant
- 2011-06-28 KR KR1020197017379A patent/KR102210982B1/ko active IP Right Grant
- 2011-06-28 ES ES11727985T patent/ES2777886T3/es active Active
- 2011-06-28 PT PT117279851T patent/PT2588114T/pt unknown
-
2012
- 2012-10-27 EC ECSP12012359 patent/ECSP12012359A/es unknown
- 2012-12-12 GT GT201200336A patent/GT201200336A/es unknown
- 2012-12-12 GT GT201200336AK patent/GT201200336AA/es unknown
- 2012-12-12 GT GT201200336BL patent/GT201200336BA/es unknown
- 2012-12-13 MX MX2019004393A patent/MX2019004393A/es unknown
- 2012-12-21 ZA ZA2012/09743A patent/ZA201209743B/en unknown
- 2012-12-26 CL CL2012003685A patent/CL2012003685A1/es unknown
- 2012-12-28 CO CO12235600A patent/CO6640328A2/es not_active Application Discontinuation
-
2015
- 2015-07-28 EC ECIEPI201532906A patent/ECSP15032906A/es unknown
- 2015-07-28 EC ECIEPI201532911A patent/ECSP15032911A/es unknown
-
2020
- 2020-01-30 HR HRP20200155TT patent/HRP20200155T1/hr unknown
-
2021
- 2021-10-14 LT LTPA2021523C patent/LTPA2021523I1/lt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR122019008317A2 (pt) | 2020-09-29 |
| MX339952B (es) | 2016-06-20 |
| ECSP12012359A (es) | 2013-03-28 |
| MX364971B (es) | 2019-05-16 |
| ZA201209743B (en) | 2014-03-26 |
| KR20190073598A (ko) | 2019-06-26 |
| CL2012003685A1 (es) | 2013-07-05 |
| ECSP15032911A (es) | 2016-01-29 |
| PT2588114T (pt) | 2020-02-20 |
| KR102210982B1 (ko) | 2021-02-02 |
| CO6640328A2 (es) | 2013-03-22 |
| ES2777886T3 (es) | 2020-08-06 |
| GT201200336BA (es) | 2017-10-23 |
| GT201200336AA (es) | 2017-10-23 |
| HUE047689T2 (hu) | 2020-05-28 |
| MX2012014629A (es) | 2013-05-06 |
| ECSP15032906A (es) | 2016-01-29 |
| DK2588114T3 (da) | 2020-02-17 |
| MX2019004393A (es) | 2019-09-09 |
| GT201200336A (es) | 2014-01-14 |
| LTPA2021523I1 (lt) | 2021-11-10 |
| LT2588114T (lt) | 2020-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013529665A5 (lt) | ||
| AU2022231672B2 (en) | Method for the management of dysmenorrhea and menstrual pain | |
| HRP20240121T1 (hr) | Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine | |
| WO2011160136A3 (en) | Progesterone containing oral dosage forms and related methods | |
| NZ605176A (en) | Pharmaceutical composition comprising drospirenone and contraceptive kit | |
| WO2013022783A3 (en) | Progesterone containing oral dosage forms and related methods | |
| JP2018527305A5 (lt) | ||
| JP2015531400A5 (lt) | ||
| AU2016425935B2 (en) | Method for the management of dysmenorrhea and menstrual pain | |
| US20100086599A1 (en) | Oral modified release formulations | |
| JP2010525050A5 (lt) | ||
| TW200831107A (en) | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | |
| JP2009512658A5 (lt) | ||
| JP2006104221A5 (lt) | ||
| WO2007106264A3 (en) | Extended cycle multiphasic oral contraceptive method | |
| JP2013509395A5 (lt) | ||
| AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
| RU2011103136A (ru) | Фармацевтическая композиция на основе тонкоизмельченного прогестерона и ее применения | |
| JP2013516493A5 (lt) | ||
| JP2020503269A5 (lt) | ||
| JP2020500864A5 (lt) | ||
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| PT1740163E (pt) | Preparação contraceptiva multifásica à base de um estrogénio natural | |
| RU2017127509A (ru) | Композиции и способы для улучшенного мышечного метаболизма | |
| WO2012020301A3 (en) | Oral controlled release pharmaceutical compositions of blonanserin |